Identifying high risk factors in locally advanced rectal cancer patients with ypT0-2N0 after preoperative chemoradiation

被引:0
作者
Wan, Jue-Feng [1 ]
Liu, Ming-Hui [2 ]
Yang, Li-Feng [1 ]
Zhu, Ji [1 ]
Li, Gui-Chao [1 ]
Zhang, Zhen [1 ,3 ]
机构
[1] Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, 270 Dongan Rd, Shanghai 200032, Peoples R China
[2] Fudan Univ, Dept Integrated Therapy, Shanghai Canc Ctr, 270 Dongan Rd, Shanghai 200032, Peoples R China
[3] Fudan Univ, Dept Oncol, Shanghai Med Coll, 270 Dongan Rd, Shanghai 200032, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2016年 / 9卷 / 03期
关键词
Rectal cancer; risk factors; good response; SEER; LYMPH-NODE RETRIEVAL; III COLON-CANCER; POSTOPERATIVE CHEMOTHERAPY; NEOADJUVANT TREATMENT; ADJUVANT TREATMENT; SURGICAL SPECIMEN; COLORECTAL-CANCER; STAGE-II; CHEMORADIOTHERAPY; FLUOROURACIL;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: The objective of this study was to identify high risk factors for survival in locally advanced rectal cancer patients with ypT0-2N0 after neoadjuvant chemoradiation. Methods: In this study, Surveillance, Epidemiology, and End Results Program (SEER)-registered rectal cancer patients, and patients from Fudan University Shanghai Cancer Center (FUSCC) after preoperative chemoradiation were combined to identify poor prognostic patients with ypT0-2N0. Results: 2375 patients from SEER data and 106 patients from FUSCC were analyzed. The SEER data showed that less than 12 lymph nodes and mucinous/signet ring cancer were the two risk factors. The 5-year cancer specific survival (CSS) in patients with none, one or two risk factors was 91.5%, 88.5% and 70.3%, respectively (P < 0.001). Our cancer center data showed that less than 12 lymph nodes and mucinous/signet ring cancer were also the two risk factors. The 3-year disease free survival (DFS) in patients with none, one or two risk factors was 96.2%, 85% and 37.5%, respectively (P = 0.013). Conclusions: Two risk factors were identified in this study that correlated independently with a worse survival in patients with ypT0-2N0. The current results indicated that adjuvant chemotherapy may be not spared in these patients who have 1 or 2 risk factors.
引用
收藏
页码:6461 / 6468
页数:8
相关论文
共 23 条
  • [1] Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
    Andre, T
    Boni, C
    Mounedji-Boudiaf, L
    Navarro, M
    Tabernero, J
    Hickish, T
    Topham, C
    Zaninelli, M
    Clingan, P
    Bridgewater, J
    Tabah-Fisch, I
    de Gramont, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) : 2343 - 2351
  • [2] Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
    Andre, Thierry
    Boni, Corrado
    Navarro, Matilde
    Tabernero, Josep
    Hickish, Tamas
    Topham, Clare
    Bonetti, Andrea
    Clingan, Philip
    Bridgewater, John
    Rivera, Fernando
    de Gramont, Aimery
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) : 3109 - 3116
  • [3] Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979
  • [4] The staging of colorectal cancer: 2004 and beyond
    Compton, CC
    Greene, FL
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (06) : 295 - 308
  • [5] Lymph Node Retrieval after Preoperative Chemoradiotherapy for Rectal Cancer
    Damin, Daniel C.
    Rosito, Mario A.
    Contu, Paulo C.
    Tarta, Claudio
    Ferreira, Paulo R.
    Kliemann, Lucia M.
    Schwartsmann, Gilberto
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (08) : 1573 - 1580
  • [6] Less Than 12 Nodes in the Surgical Specimen After Total Mesorectal Excision Following Neoadjuvant Chemoradiation: It means more than you think!
    de Campos-Lobato, Luiz Felipe
    Stocchi, Luca
    de Sousa, Joao Batista
    Buta, Martin
    Lavery, Ian C.
    Fazio, Victor W.
    Dietz, David W.
    Kalady, Matthew F.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (11) : 3398 - 3406
  • [7] Edge S.B., 2010, AJCC cancer staging manual, V649
  • [8] Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer
    Fietkau, Rainer
    Barten, Malte
    Klautke, Gunther
    Klar, Ernst
    Ludwig, Kaja
    Thomas, Hartmut
    Brinckmann, Wolfgang
    Friedrich, Andreas
    Prall, Friedrich
    Hartung, Gernot
    Kuechenmeister, Ute
    Kundt, Gunther
    [J]. DISEASES OF THE COLON & RECTUM, 2006, 49 (09) : 1284 - 1292
  • [9] Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?
    Gao, Peng
    Song, Yong-xi
    Sun, Jing-xu
    Chen, Xiao-wan
    Xu, Ying-ying
    Zhao, Jun-hua
    Huang, Xuan-zhang
    Xu, Hui-mian
    Wang, Zhen-ning
    [J]. BMC CANCER, 2014, 14
  • [10] Gill R D, 1992, Math Popul Stud, V3, P259